2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 28, 2013
Grant Date -
Aug 18, 2011
app pub date -
Jan 28, 2011
filing date -
Aug 2, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the use of masitinib or a pharmaceutically acceptable salt thereof, and in particular of masitinib mesylate, for the preparation of a medicament for the treatment of GIST, to the use of this therapy for the treatment of GIST, and a method of treating mammals, including humans, suffering from GIST by administering to said mammal in need of such treatment an effective dose of masitinib, and in particular masitinib mesylate.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully